RAPT Therapeutics (RAPT) Other Accumulated Expenses (2020 - 2024)
Historic Other Accumulated Expenses for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $168000.0.
- Therapeutics' Other Accumulated Expenses rose 769.23% to $168000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $168000.0, marking a year-over-year increase of 769.23%. This contributed to the annual value of $178000.0 for FY2023, which is 2521.01% down from last year.
- Per Therapeutics' latest filing, its Other Accumulated Expenses stood at $168000.0 for Q3 2024, which was up 769.23% from $126000.0 recorded in Q2 2024.
- Therapeutics' 5-year Other Accumulated Expenses high stood at $436000.0 for Q1 2020, and its period low was $117000.0 during Q1 2022.
- Moreover, its 5-year median value for Other Accumulated Expenses was $236000.0 (2023), whereas its average is $247684.2.
- In the last 5 years, Therapeutics' Other Accumulated Expenses plummeted by 6538.46% in 2022 and then soared by 10170.94% in 2023.
- Over the past 5 years, Therapeutics' Other Accumulated Expenses (Quarter) stood at $328000.0 in 2020, then fell by 22.56% to $254000.0 in 2021, then fell by 6.3% to $238000.0 in 2022, then dropped by 25.21% to $178000.0 in 2023, then fell by 5.62% to $168000.0 in 2024.
- Its last three reported values are $168000.0 in Q3 2024, $126000.0 for Q2 2024, and $203000.0 during Q1 2024.